IMMUNE PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about news in IMMUNE PHARMACEUTICALS INC.

The service is free and you can unsubscribe at any time.

General | People (118) | Filings (859) | Investment rounds (1) | Annual reports (6) | Stock | News

Industry: PHARMACEUTICAL PREPARATIONS [2834]

CIK Number: 0001208261
IRS Number: 521841431

IMMUNE PHARMACEUTICALS INC is a publicly traded company

Trading symbol: IMNP

IMMUNE PHARMACEUTICALS INC is on the market more than 5 years.

News

2017-08-19

Can This Stock Price Climb The Ladder: Immune Pharmaceuticals, Inc. (NASDAQ:IMNP)?
FLBC News
Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) are valued at $1.26 at the time of writing and have moved 2.44% since the open.

2017-08-18

Small Cap Concentration on Immune Pharmaceuticals, Inc. (NASDAQ:IMNP)
FLBC News
Savvy stock holders on the lookout for bargain basement prices are starting to take a closer look at Immune Pharmaceuticals, Inc. (NASDAQ:IMNP). The stock is currently valued at $1.22 after moving -13.19% over the past week and -0.81% in the most ...
What Are The Drivers Of Immune Pharmaceuticals Inc's (IMNP) Risks? - Simply Wall St
Technicals in The Spotlight For Immune Pharmaceuticals Inc (IMNP) - Baxter Review

2017-08-17

Marching to the Beat of Their Own Drum, Update on Immune Pharmaceuticals, Inc.
FLBC News
Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) are being monitored closely by investors today as the name is currently priced at $1.21, a -3.97% difference from where it most recently opened.
Immune Pharmaceuticals Inc (NASDAQ:IMNP) has analysts on the Bullish side this ... - Finance News Daily
DelMar Pharmaceuticals, Inc. (:DMPI) & Immune Pharmaceuticals, Inc. (NASDAQ ... - Geneva Journal

2017-08-16

Tenkan Sen Signals Negative Momentum For Immune Pharmaceuticals Inc (IMNP)
Financial Newsweek
Immune Pharmaceuticals Inc (IMNP)'s moving averages reveal that the Tenkan line of the shares are below the Kijun-Sen line, indicating potential downward momentum building in the bearish chart.

2017-08-14

Immune Pharmaceuticals Appoints Tony Fiorino, MD, PhD as Chief Medical Officer ...
Business Wire (press release)
NEW YORK--(BUSINESS WIRE)--Immune Pharmaceuticals (NASDAQ:IMNP) (the “Immune” or the “Company”) announced today that it has appointed Tony Fiorino, MD, PhD to the joint position of Chief Medical Officer and Chief Operating Officer.

2017-08-12

Immune Pharmaceuticals Inc (IMNP) Sets New 52-Week Low at $2.05
Week Herald
Immune Pharmaceuticals logo Immune Pharmaceuticals Inc (NASDAQ:IMNP) reached a new 52-week low during mid-day trading on Wednesday .
Volatility Spiking as Shares Ride the Wave: Immune Pharmaceuticals, Inc ... - BVN

2017-08-10

Tale of the Ticker: Immune Pharmaceuticals Inc (IMNP) Moves on Volume
Clayton News
Needle moving action has been spotted in Immune Pharmaceuticals Inc (IMNP) as shares are moving today on volatility -3.47% or -0.05 from the open.

IMMUNE PHARMACEUTICALS INC address

430 EAST 29TH STREET
SUITE 940
NEW YORK
10016

Former name

Former name of this company was EPICEPT CORP, date of change: 2002-11-29.

Company jurisdiction

DELAWARE

Entity type

Corporation

Earliest known filing

November 2002

Latest known filing

August 2017

Company filings

SEC filings are a great source of information for companies including investments, company events, and all sorts of other information.

IMMUNE PHARMACEUTICALS INC has 859 filings. View IMMUNE PHARMACEUTICALS INC filings.

Annual Reports

Quarterly Reports

Latest company events

Investment Rounds

IMMUNE PHARMACEUTICALS INC recieved 1 investments.

People

We have found 118 people related to IMMUNE PHARMACEUTICALS INC.

Similar companies

IMMUNEX CORP /DE/, IMMUNE AMERICA INC, IMMUNE RESPONSE INC, IMMUNETICS, INC., IMMUNE NETWORK LTD, IMMUNE SYSTEM LTD, IMMUNEREGEN BIOSCIENCES INC, IMMUNE MODULATION INC, IMMUNEWORKS LLC, Immune Design Corp., IMMUNE DESIGN CORP, IMMUNETRICS INC, Immunet Corp, Immune Response BioPharma, Inc., ImmuneXcite, Inc., Immune Therapeutics, Inc., Immune-Onc Therapeutics, Inc.